Sucralfate oral suspension

Product NDC
68462-827
11-digit product format
684620827
Labeler code
68462
Product ID
68462-827_1e595c2a-edd0-43f7-a2db-69553b9557d9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
sucralfate
Dosage form
SUSPENSION
Route
ORAL
Labeler
Glenmark Pharmaceuticals Inc., USA
Application
ANDA212141
Marketing category
ANDA
Marketing start
2026-01-05
Substance
SUCRALFATE
Active strength
1 g/10mL
Pharmacologic classes
Aluminum Complex [EPC], Organometallic Compounds [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A212141-001SUCRALFATESUCRALFATE1GM/10MLSUSPENSION / ORALAB2026-01-05

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A212141-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A212141-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2026-01-05caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A212141-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2026-01-05011fe1cb6892…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A212141-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2026-01-05a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A212141-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A212141-001AB1011fe1cb6892…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A212141-001AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Sucralfate oral suspension
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SUCRALFATE1 g/10mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
XX73205DH5Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
313123Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1e595c2a-edd0-43f7-a2db-69553b9557d9Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
01e96ee1-fe82-0132-025c-ec1559bf8b6eProduct name520260127
f9fa5fa8-e047-2182-3e2c-c4a9ec6531cdProduct name320240508
6084a4f4-5437-c9a5-caec-5361ee075a59Product name120140508
90c5639a-61b0-88d6-ddcf-21888e94869aProduct name120140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
9869efd7-d6dd-0665-5b67-53adbe6ef15eProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68462-827-61Sucralfate oral suspension420 mL in 1 BOTTLESUSPENSION4201

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sucralfate oral suspensionSUCRALFATEGlenmark Pharmaceuticals Inc., USA1e595c2a-edd0-43f7-a2db-69553b9557d92026-01-06Warnings, Adverse reactionsExact identifier
application applno (ANDA): 212141
application number: ANDA212141
ndc (product): 68462-827

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
313123sucralfate 1 GM in 10 mL Oral SuspensionPSN1e595c2a-edd0-43f7-a2db-69553b9557d91
313123sucralfate 100 MG/ML Oral SuspensionSCD1e595c2a-edd0-43f7-a2db-69553b9557d91
313123sucralfate 1 GM per 10 ML Oral SuspensionSY1e595c2a-edd0-43f7-a2db-69553b9557d91

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
68462-827-6168462082761420 mL in 1 BOTTLE (68462-827-61) 420 ml2026-01-05NoNoCurrent